| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |